US Patent Issued to Corcept Therapeutics on May 12 for "Treatment of, and differential diagnosis between, ACTH-dependent Cushing's syndrome and ACTH-independent Cushing's syndrome" (Florida, California Inventors)

ALEXANDRIA, Va., May 12 -- United States Patent no. 12,625,150, issued on May 12, was assigned to Corcept Therapeutics Inc. (Redwood City, Calif.).

"Treatment of, and differential diagnosis between, ACTH-dependent Cushing's syndrome and ACTH-independent Cushing's syndrome" was invented by Andreas G. Moraitis (Sunny Isles Beach, Fla.) and Joseph Belanoff (Woodside, Calif.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Methods for treating and differential diagnosis between ACTH-Dependent and ACTH-Independent Cushing's syndrome are disclosed, in which a glucocorticoid receptor antagonist (GRA) is administered to a Cushing's syndrome patient with a basal ACTH level less than about 25 pg/mL. If i) the patients b...